Cargando…

Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular fibrillation

Detalles Bibliográficos
Autores principales:	Fleeman, Blake E., Avitall, Boaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420022/ https://www.ncbi.nlm.nih.gov/pubmed/28491766 http://dx.doi.org/10.1016/j.hrcr.2016.08.018

Ejemplares similares

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology
por: Rathore, Azeem, et al.
Publicado: (2023)

Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks
por: Fleeman, Blake E., et al.
Publicado: (2019)

Electrical injury‐induced ventricular fibrillation documented and treated with an implantable cardioverter defibrillator
por: Higami, Shigeo, et al.
Publicado: (2023)

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
por: Mohri, Takato, et al.
Publicado: (2017)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type
por: Park, Y M, et al.
Publicado: (2023)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
por: Goldstein, Sarah A., et al.
Publicado: (2023)

Ventricular Fibrillation Cardiac Arrest in African American Male with Apical Hypertrophic Cardiomyopathy
por: Volney, Giselle, et al.
Publicado: (2018)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Inappropriate Implantable Cardioverter-Defibrillation Detection of Ventricular Fibrillation Induced by Transcutaneous Electrical Nerve Stimulation
por: Mohammad, Shireen, et al.
Publicado: (2022)

Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator
por: Kumar, Rajnish, et al.
Publicado: (2018)

Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports
por: Park, Yae Min, et al.
Publicado: (2021)

Pacemaker Treatment for Apical Hypertrophic Cardiomyopathy in the Setting of an Apical Ventricular Aneurysm
por: Toyoda, Shigeru, et al.
Publicado: (2021)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Usefulness of lead repositioning to improve subcutaneous electrocardiogram sensing in patients with arrhythmogenic right ventricular cardiomyopathy with subcutaneous implantable cardioverter-defibrillator
por: Sasaki, Shingo, et al.
Publicado: (2020)

Additional left ventricular septal lead facilitates R-wave sensing of implantable cardioverter-defibrillator in arrhythmogenic right ventricular cardiomyopathy: a case report
por: Lu, Wenzhao, et al.
Publicado: (2023)

Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
por: Kurath-Koller, Stefan, et al.
Publicado: (2020)

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Left ventricular strain and myocardial work in apical hypertrophic cardiomyopathy
por: Mihos, Christos G., et al.
Publicado: (2023)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Left ventricular apical aneurysm resection and mitral valve replacement for apical hypertrophic cardiomyopathy
por: Nishiori, Hironobu, et al.
Publicado: (2023)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
por: Kiamanesh, Omid, et al.
Publicado: (2015)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation
por: Rochelson, Ellis, et al.
Publicado: (2018)

Undersensing of ventricular fibrillation by a biventricular implantable cardioverter‐defibrillator: What is the cause and the troubleshooting?
por: Le, Kien Vo, et al.
Publicado: (2019)

Living with hypertrophic cardiomyopathy and an implantable defibrillator
por: Magnusson, Peter, et al.
Publicado: (2017)

Apical hypertrophic cardiomyopathy with hemodynamically unstable ventricular arrhythmia – Atypical presentation
por: Chaturvedi, Hemant, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus
por: Raza, Munis, et al.
Publicado: (2018)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Steinberg, Christian, et al.
Publicado: (2020)

Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy()
por: Flett, Andrew S., et al.
Publicado: (2015)

Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients
por: Al-Ghamdi, Bandar, et al.
Publicado: (2018)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
por: Noordman, Alwin B. P., et al.
Publicado: (2021)

Mid-Ventricular Hypertrophic Obstructive Cardiomyopathy Complicated by an Apical Aneurysm, Presenting as Ventricular Tachycardia
por: Petrou, Emmanouil, et al.
Publicado: (2014)

Obstetric hemorrhage in a case of hypertrophic obstructive cardiomyopathy with automatic implantable cardioverter defibrillator: Anaesthesia and intensive care management
por: Mishra, Sandeep Kumar, et al.
Publicado: (2016)

Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Development of ventricular fibrillation after implantation of a biventricular implantable cardioverter defibrillator: what is the mechanism?
por: Chemello, Diego, et al.
Publicado: (2017)

Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator
por: Luo, Jijian, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_q0vbmhjemf2f3fegddq4l565nr